Could CaMKK2 enzyme be the key to treating bipolar disorder?

Researchers explore the role of the CaMKK2 signaling pathway in bipolar disorder, suggesting it as a new treatment target. By targeting this enzyme, scientists aim to develop more effective therapies for bipolar symptoms and metabolic dysfunction.

Research uncovers dengue’s surprising invasion strategies

Mosquito-borne viral infections once confined to tropical regions are spreading. Dengue virus infects up to 400 million people worldwide each year according to World Health

July 22, 2024

Infectious Disease Groups Urge CMS to Retire Sepsis Treatment Guidelines

The Centers for Medicare & Medicaid Services’ (CMS) current guidelines for treating sepsis should be retired and replaced with more performance-based measures, according to a

November 3, 2023

Others by Eyenovia for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.